Stratos Wealth Partners’s CapForce IBD 50 ETF FFTY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-8,812
Closed -$237K 1159
2022
Q2
$237K Buy
8,812
+150
+2% +$4.82K 0.01% 1030
2022
Q1
$339K Sell
8,662
-49
-0.6% -$1.9K 0.01% 946
2021
Q4
$399K Sell
8,711
-825
-9% -$39.4K 0.01% 899
2021
Q3
$452K Sell
9,536
-100
-1% -$4.67K 0.01% 788
2021
Q2
$447K Hold
9,636
0.01% 811
2021
Q1
$423K Sell
9,636
-145
-1% -$6.58K 0.01% 763
2020
Q4
$402K Hold
9,781
0.01% 743
2020
Q3
$365K Sell
9,781
-1,990
-17% -$73.3K 0.01% 719
2020
Q2
$405K Sell
11,771
-140
-1% -$4.35K 0.01% 669
2020
Q1
$333K Sell
11,911
-2,854
-19% -$95K 0.02% 656
2019
Q4
$513K Sell
14,765
-14,777
-50% -$500K 0.02% 586
2019
Q3
$953K Sell
29,542
-1,093
-4% -$37.4K 0.04% 376
2019
Q2
$1.05M Sell
30,635
-80
-0.3% -$2.7K 0.05% 357
2019
Q1
$1.03M Sell
30,715
-5,185
-14% -$163K 0.05% 353
2018
Q4
$992K Sell
35,900
-1,844
-5% -$57.2K 0.05% 330
2018
Q3
$1.45M Buy
37,744
+23,680
+168% +$871K 0.06% 268
2018
Q2
$494K Buy
14,064
+1,600
+13% +$55.8K 0.02% 571
2018
Q1
$415K Buy
+12,464
New +$424K 0.02% 610

Other funds holding FFTY

Stratos Wealth Partners's FFTY Position: Q3 2022 in Review

Stratos Wealth Partners sold out of CapForce IBD 50 ETF (FFTY) in Q3 2022, closing a stake of 8,812 shares — an estimated $237K sold.

Stratos Wealth Partners first reported a position in FFTY in Q1 2018 and held it in 18 quarters. The position peaked at $1.45M in Q3 2018. 50 funds tracked by Wall St. Rank hold FFTY as of Q3 2022.

  • Stratos Wealth Partners reported no remaining CapForce IBD 50 ETF position as of Q3 2022 after selling out during the quarter.
  • Stratos Wealth Partners sold 8,812 CapForce IBD 50 ETF shares in Q3 2022, an estimated $237K.
  • Stratos Wealth Partners first reported a position in CapForce IBD 50 ETF in Q1 2018 and held it in 18 quarters.
  • Stratos Wealth Partners's CapForce IBD 50 ETF position peaked at $1.45M in Q3 2018.
  • 50 funds tracked by Wall St. Rank held CapForce IBD 50 ETF as of Q3 2022.

Based on Stratos Wealth Partners's 13F filing for Q3 2022, filed 24 Oct 2022.